Research institute in
Zug
269 companies in Research institute based in Zug — name and year of registration from the commercial register.
50 of 269 companies
Holcim Technology Ltd
Since 1976 · 101–500 empl.4.7(22)
Holcim Technology Ltd provides building materials and building solutions, including decarbonized cement, circular aggregates and ready-mix concrete, for infrastructure, industrial and building applications. It also focuses on decarbonizing construction and on energy-efficient building systems and surfacing solutions.
Inoiv GmbH
Since 2017 · 1–10 empl.4.7(546)
Inoiv GmbH develops and sells cosmetics made in Switzerland for skin, hair and beard care. Its range includes facial and hair-care products, derma rollers, and products for eyelashes and eyebrows.
Wolke, Candoo Labs
Since 2016 · 1–10 empl.4.6(47)
Wolke, Candoo Labs is an international blockchain ecosystem builder that provides coworking and private offices, an accelerator program, event and meeting spaces, and advisory and company-setup services.
Dotphoton AG
Since 2018 · 11–20 empl.5.0(4)
Dotphoton AG develops software for image processing and image data management. Its products include solutions for RAW image compression, storing and transferring image data, and generating synthetic images for AI applications.
Premier Research Group SA
Since 1997 · 1–10 empl.
Premier Research Group SA is a clinical research and consulting provider for the life sciences sector. The company supports the development of drugs, medical devices, and diagnostics through services in study design, clinical development, regulatory strategy, and technology.
Corza Device GmbH
Since 2001 · 1–10 empl.
Corza Device GmbH develops and distributes surgical solutions for a range of medical specialties. The company offers products and services in biosurgery, biomedical textiles, ophthalmology, and wound closure.
BJH - Natur- und Resonanzforschung AG
Since 2003 · 1–10 empl.
BJH Europe is engaged in the development, manufacture and distribution of health products, particularly dietary supplements, care products and cosmetics based on natural ingredients, which are intended to support human health and well-being. The company's core activity lies in the research, development and marketing of products that promote and strengthen the health of the heart, brain, gut, skin and other areas of the body.
Novelpharm AG
Since 2006 · 1–10 empl.
Novelpharm AG is active in research and development and has a product portfolio. The company aims to find natural solutions to diseases and make them usable for patients.
Lowalt Technologies AG
Since 2006 · 1–10 empl.
Olympic Therapeutics AG
Since 2008 · 1–10 empl.
Olympic Therapeutics AG develops bacteriophages and technologies for their use in treating MRSA. It identifies and develops phage candidates for MRSA and other bacterial infections, with plans for their clinical development.
Meditrial Europe AG
Since 2009 · 11–20 empl.
Meditrial Europe AG is a contract research organization serving pharmaceutical, medical device and biotechnology companies. Its services include clinical study design and management, regulatory support, post-market activities and market access, alongside digital tools for clinical data and trial management.
RS DYNAMICS GmbH
Since 2010 · 1–10 empl.
The core activity of RS DYNAMICS is the development and manufacture of specialized devices and technologies for various application areas, in particular: 1. Security: Explosive and drug detection devices, as well as combination devices for the detection of explosives and radioactive materials. 2. Earth Sciences: Technology and instruments for mapping and monitoring soil and groundwater pollution. 3. Medical Technology: Devices for the early detection of cancer, particularly breast cancer, as well as instruments to support researchers in medical technology. The company also offers customer-specific solutions and services in these areas.
AssesSurgery GmbH
Since 2013 · 1–10 empl.
AssesSurgery GmbH provides a web-based service for surgeons and researchers working on surgical quality improvement. Its tools include Clavien-Dindo grading of postoperative complications, calculators for estimating surgical costs and the BAR score for liver transplantation, and assistance with using these tools.
CRISPR Therapeutics AG
Since 2013 · 101–500 empl.
The core activity of CRISPR Therapeutics is the development of gene therapeutic medicines, particularly through the application of CRISPR-Cas9 technology, to cure diseases at the molecular level. The company focuses on developing medicines for various diseases such as sickle cell anemia, β-thalassemia, cancer, autoimmune disorders, and regenerative medicine.
Alnylam Switzerland GmbH
Since 2015 · 21–50 empl.
The company is a pharmaceutical or biotechnology company specializing in the development and manufacture of medicines for rare diseases. The core activity includes research and development of RNAi-based therapies, the manufacture and marketing of medicines, as well as the provision of patient services, including genetic counseling and patient advocacy.
Sarepta International Holdings GmbH
Since 2017 · 1–10 empl.
The core activity of Sarepta Therapeutics is the development and manufacturing of gene therapies for the treatment of rare diseases, particularly muscular dystrophies such as Duchenne muscular dystrophy, limb-girdle muscular dystrophy (LGMD), and Charcot-Marie-Tooth disease. The company focuses on researching and developing precision gene medicine and aims to increase efficiency in drug development and shorten the time from laboratory to patient.
Web 3.0 Technologies Stiftung
Since 2017 · 21–50 empl.
Web 3.0 Technologies Stiftung supports research and development in decentralized technologies and applications. Its activities include supporting open-source projects, research, education, and open protocols for a decentralized internet.
Zinzino IP AG
Since 2017 · 1–10 empl.
Zinzino IP AG offers nutritional supplements, skincare products and home health tests under the Zinzino brand. Its range includes omega supplements, health tests and products for immune support, gut health, skin nutrition and weight management.
Aphaia Pharma AG
Since 2018 · 21–50 empl.
The core activity of Aphaia Pharma AG is the development and marketing of pharmaceuticals, particularly in the fields of life sciences and biotechnology. The company focuses on the research and development of innovative therapeutics and medications, particularly in the areas of microvascular medicine and the treatment of diseases such as obesity and metabolic disorders.
LifeScan Europe GmbH
Since 2018 · 1–10 empl.
LifeScan Europe GmbH develops and markets products and digital solutions for diabetes management. Its portfolio includes blood glucose meters, test strips, lancets, integrated digital health platforms, and hospital point-of-care systems.
Global Power and Propulsion Society
Since 2018 · 11–20 empl.
Global Power and Propulsion Society is a volunteer-led international community for professionals in industry and academia working with turbomachinery. It provides a forum to exchange and publish research and ideas on power generation and aeronautical propulsion, and organizes technical events.
Insmed Switzerland GmbH
Since 2019 · 11–20 empl.
Insmed Corporation focuses on the development and commercialization of drugs for rare and serious diseases, particularly in the areas of respiratory diseases and rare diseases. The core activities include research and development of new drugs, the acquisition and licensing of clinical and commercial assets, the conduct of clinical trials, and the commercialization of drugs in the US, Europe, Japan, and other regions.
G&L Scientific (Schweiz) GmbH
Since 2019 · 11–20 empl.
G&L Scientific (Schweiz) GmbH operates an integrated product development and market access platform providing consulting and services to pharmaceutical, biopharmaceutical and biotechnology companies. Services include pharmaceutical and clinical development, regulatory submissions, market access, commercialization, and quality and compliance support.
PlantingSpace AG
Since 2019 · 11–20 empl.
The core activity of PlantingSpace AG encompasses the development of software and technologies, particularly in the areas of: Cloud infrastructure and DevOps practices, Research and development in symbolic processing, compilers, and programming languages, Development of inference algorithms for artificial intelligence models, Frontend development for web applications. The company appears to focus on developing technical solutions for various areas, particularly in software development and artificial intelligence.
Deciphera Pharmaceuticals (Schweiz) AG
Since 2019 · 101–500 empl.
The core activity of Deciphera Pharmaceuticals, LLC is the development and manufacture of cancer treatments, particularly through the development of kinase inhibitors that target specific enzymes involved in the development and spread of cancer.
GOWID AG Green our World Industries Development
Since 2019 · 11–20 empl.
GOWID AG Green our World Industries Development develops OVZ CARBON for applications in areas including medicine, filtration, desalination, insulation, fire protection, energy storage, exhaust technology, vehicle manufacturing and turbines.
Nektar Therapeutics Europe GmbH
Since 2021 · 1–10 empl.
Nektar Therapeutics Europe GmbH develops novel therapies for autoimmune and inflammatory diseases according to the information presented on the website. Its work focuses on immune modulation, including investigational medicines targeting regulatory T cells and other immunology pathways.
DEFI Stiftung
Since 2021 · 1–10 empl.
The core activity of StiftungSchweiz is to provide an online platform and digital tools for philanthropy, particularly for foundations, non-profit organizations and companies, to enable effective, networked and transparent donations and sponsorships.
Jazz Pharmaceuticals Switzerland GmbH
Since 2021 · 1–10 empl.
Jazz Pharmaceuticals Switzerland GmbH is the Swiss company of the global biopharmaceutical group Jazz Pharmaceuticals. Its activities include the distribution and wholesale of pharmaceutical products, their marketing, and related services.
Orchard Therapeutics (Switzerland) GmbH
Since 2021 · 1–10 empl.
Orchard Therapeutics (Switzerland) GmbH develops gene therapies for rare inherited diseases. Its work focuses on ex vivo HSC gene therapy, in which a patient’s own blood stem cells are genetically modified outside the body and then reinfused.
Global Liberty Institute
Since 2022 · 21–50 empl.
Global Liberty Institute is a non-profit organization that mentors, connects, and supports young leaders. It organizes programs and events such as Rising Leaders Summits and Policy Forums with a focus on liberty, economic freedom, and free speech.
Nomic Stiftung
Since 2022 · 11–20 empl.
Nomic Stiftung is a non-profit foundation that provides open-source software for Ethereum development. Its projects include Hardhat, tools for Solidity compilers, and an Ethereum development runtime.
ACROBiosystems AG
Since 2022 · 1–10 empl.
ACROBiosystems AG supplies life-science reagents and services, including recombinant proteins, antibodies, cell lines, cell culture reagents and assay kits. The company also provides GMP-grade materials, custom protein services and analytical/quality-control services to support cell and gene therapy development.
Novotech Clinical Research AG
Since 2023 · 1–10 empl.
Novotech Clinical Research AG is a clinical research organization (CRO) that provides clinical trial and advisory services for biotech and small to mid-sized pharmaceutical companies. The company supports drug development through services including clinical operations, site selection, regulatory consulting, biometrics, laboratory services, and therapeutic expertise.
Piëch Labs AG
Since 2017 · 11–20 empl.
Piëch Labs AG develops high-performance drivetrains and battery technologies for electric sports cars, including immersion cooling for cells and the Track2Charge fast-charging system.
Molecular Modelling Laboratory GmbH
Since 2018 · 1–10 empl.
The core activity of Molecular Modelling Laboratory (MML) involves the application of quantum chemical modeling, artificial intelligence (AI), and electron microscopy for the development of immunointerventions and drug development. Specifically, the focus is on researching quantum mechanical processes in immune reactions and applying this knowledge to the therapy of infectious diseases, immune disorders, neurological diseases, and aging processes. Additionally, MML offers services in the field of computer-aided analysis of drugs, including the prediction of crystal structures and the stability of amorphous solids.
Qualitas AG
Since 2005 · 11–20 empl.5.0(4)
Qualitas AG provides IT solutions and quantitative genetics services for the Swiss livestock sector. Its activities include software and mobile app development, breeding value estimation for cattle, dairy sheep and goats, and services for genomic selection.
PIX Moving GmbH
Since 2024 · 11–20 empl.
PIX Moving GmbH is a city robotics company that develops autonomous, modular mobility platforms such as RoboBus, RoboTaxi, RoboShop and RoboVan. The company also provides development kits (PIXKIT) and a Robot-as-a-Service offering for configurable mobile spaces, including hardware and software integration support.
Packgene Biotech AG
Since 2024 · 1–10 empl.
Packgene Biotech AG provides contract research and manufacturing services for cell and gene therapies, including AAV and lentivirus packaging, mRNA/LNP and plasmid production, vector design, analytical testing and GMP manufacturing services.
Stiftung CHIWI
Since 2022 · 11–20 empl.
The core activity of CHiwi Foundation is to promote scientific research in the fields of space exploration, alternative energy and advanced mathematics by awarding research grants.
Crinetics Pharmaceuticals Europe GmbH
Since 2024 · 1–10 empl.
Crinetics Pharmaceuticals Europe GmbH is a pharmaceutical company focused on the discovery, development, and commercialization of novel therapies for endocrine diseases and endocrine-related tumors. Its pipeline includes drug candidates for conditions such as acromegaly, Cushing’s syndrome, congenital adrenal hyperplasia, and neuroendocrine tumors.
Brigitte Moser Bauforschung und Kunstgeschichte GmbH
Since 2022 · 1–10 empl.
Brigitte Moser Bauforschung und Kunstgeschichte GmbH works on projects in architectural heritage, art history and cultural history. Its services include building-history research, advice and reports on historic buildings and heritage conservation, as well as writing and supporting publications and exhibitions.
Tufa Labs AG
Since 2024 · 1–10 empl.
Tufa Labs AG is an independent research group conducting fundamental research in artificial intelligence. Its work includes reasoning in large language models and reinforcement learning, research on ARC-AGI, and developing expertise and infrastructure for pre-training and post-training language models.
Trialize AG
Since 2022 · 1–10 empl.
Trialize AG provides a Clinical Trial Operating System that integrates EDC, eCOA/ePRO, eConsent, TeleVisits, RTSM, medical coding and lab modules with automation and analytics for study operations. The platform automates study build (protocol → CRFs), query handling, coding and real‑time monitoring and includes predictive models and AI‑assisted workflows.
FLARM Technology AG
Since 2006 · 11–20 empl.3.0(2)
FLARM Technology AG develops collision-warning systems for general aviation and drones. It also provides hardware modules, software and licences for integrating FLARM technology into avionics products.
Dyverto AG
Since 2022 · 1–10 empl.
The core activity of Dyverto AG is to support start-ups and young companies in the field of medical technology, particularly in the cardiovascular area. The company acts as an incubator and accelerator by identifying, developing and accompanying innovative ideas from clinical practice through patenting, prototyping and proof-of-concept phases. The goal is to transfer these ideas into new companies and secure venture capital financing.
MOHE BioTech (Suisse) SA
Since 2023 · 1–10 empl.
The core activity of Mohe BioTech is the development and provision of products and services in the field of biotechnology, which are intended for both professional and personal use.
Tufa AG
Since 2022 · 1–10 empl.
Tufa AG develops solutions in the field of deep learning. The website also provides a contact address for accounting.
Vantage Alloys AG
Since 2022 · 1–10 empl.
The core activity of Vantage Alloys AG is the trade in metals, particularly vanadium and vanadium alloys, as well as the provision of technical services and consulting in the field of metal processing and application. The company also offers research and development projects (R&D) as well as logistics and distribution services.
IIST AG
Since 2025 · 1–10 empl.
IIST AG develops and manufactures physical, chemical and biological sensors. The company offers temperature, flow, humidity, conductivity and biosensors, as well as customized sensor solutions and joint development services.
Research institute in Zug
Research institute in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of November 6, 2026
Research institute in other places
By canton